OncoGenex Announces Initiation of Phase 3 "ENSPIRIT" Trial for Patients with Advanced Non-Small Cell Lung Cancer

OncoGenex focuses on diverse molecular entities that target mechanisms of resistance and that have the potential to re-define treatment paradigms in a variety of cancers.